STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more

An FDA advisory panel recommended updating fall 2023 Covid vaccines to target the XFG variant. Pfizer and China’s Innovent Biologics announced a $10.5 billion global collaboration to develop 12 early-stage cancer drugs. The WHO fast-tracked three existing drugs for testing against the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo.